These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1552 related items for PubMed ID: 23896498

  • 1. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI, Kuo RS, Freeman WD.
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [Abstract] [Full Text] [Related]

  • 2. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [Abstract] [Full Text] [Related]

  • 3. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 4. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [Abstract] [Full Text] [Related]

  • 5. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW, Barillari G.
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [Abstract] [Full Text] [Related]

  • 6. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY, Larsen TB, Skjøth F, Rasmussen LH.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
    Lip GY, Kongnakorn T, Phatak H, Kuznik A, Lanitis T, Liu LZ, Iloeje U, Hernandez L, Dorian P.
    Clin Ther; 2014 Feb 01; 36(2):192-210.e20. PubMed ID: 24508420
    [Abstract] [Full Text] [Related]

  • 9. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ.
    Postgrad Med; 2012 Nov 01; 124(6):7-16. PubMed ID: 23322134
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
    Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J.
    Circ Cardiovasc Qual Outcomes; 2012 Jul 01; 5(4):480-6. PubMed ID: 22787066
    [Abstract] [Full Text] [Related]

  • 12. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS, Lip GY.
    Best Pract Res Clin Haematol; 2013 Jun 01; 26(2):115-29. PubMed ID: 23953900
    [Abstract] [Full Text] [Related]

  • 13. [Improvements in oral anticoagulant therapy for atrial fibrillation].
    Briongos Figuero S, García Santos-Gallego C, Badimón JJ.
    Med Clin (Barc); 2013 Dec 07; 141(11):487-93. PubMed ID: 23597953
    [Abstract] [Full Text] [Related]

  • 14. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A, Al-Majzoub O, Kanaan AO, Donovan JL, Silva M.
    Clin Ther; 2013 Jul 07; 35(7):967-984.e2. PubMed ID: 23870607
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
    Morales-Vidal S, Schneck MJ, Flaster M, Biller J.
    Expert Rev Neurother; 2012 Feb 07; 12(2):179-89; quiz 190. PubMed ID: 22288673
    [Abstract] [Full Text] [Related]

  • 18. Novel oral anticoagulants: a review of new agents.
    Wanat MA.
    Postgrad Med; 2013 Jul 07; 125(4):103-14. PubMed ID: 23933899
    [Abstract] [Full Text] [Related]

  • 19. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Berman JP, Halperin JL.
    Hosp Pract (1995); 2013 Feb 07; 41(1):37-48. PubMed ID: 23466966
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 78.